Solid Tumor Cancer

Oncology·MeSH: Urinary Bladder Neoplasms

10 drugs in development·10 companies·7 clinical trials

Drug Pipeline by Phase

Phase 1(1)

Drug	Company
axn-27m/imm27m	Instil Bio, Inc. (TIL)

Preclinical(5)

Drug	Company
CAR-T and Veto Cell combination (CAR-T Veto Cell therapy)	Cell Source, Inc. (CLCS)
ck-103	Checkpoint Therapeutics, Inc. (CKPT)
km10544	Emmaus Life Sciences, Inc. (EMMA)
pcs11t	Processa Pharmaceuticals, Inc. (PCSA)
theralink pan-tumor assay 2.0	THERALINK TECHNOLOGIES, INC. (THER)

Unknown(2)

Drug	Company
ADXS-HOT	Ayala Pharmaceuticals, Inc. (ADXS)
mn-029	MEDICINOVA INC (MNOV)

Phase 1/Phase 2(2)

Drug	Company
bnt3214	BioNTech SE (BNTX)
iov-5001	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

BioSniper tracks 10 drugs in development for Solid Tumor Cancer across 10 companies.

There are 7 clinical trials targeting Solid Tumor Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.